Collectively, these findings support the conclusion that effective tumor control requires synergistic interaction between immunogenic tumor modulation by DTIC and ACT with EGFR mCAR T cells, following CPA-mediated lymphodepletion. This evidence concerns the gene EGFR and neoplasm.